Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Allergy Therapeutics"
Count: 117
Selected: 0
NCT05476497Phase I Trial to Evaluate VLP Peanut in Healthy and Peanut Allergic Subjects
NCT05540717Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass Pollen
NCT05455749Effect of holoBLG on Cat Allergic Patients
NCT05186025Tyrosine Allergoid Paediatric and Adult Study
NCT04687059An Exploratory Study of PQ Grass 27600 SU
NCT00109759Evaluation of Safety and Tolerability of Tyrosine Adsorbed Ragweed Pollen Allergoid With MPL (Monophosphoryl Lipid A)
NCT00133146Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Grass Pollen Allergy Vaccine
NCT00258635Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment of Residual Allergenicity Using Skin Prick Test
NCT00133159Different Doses of Tyrosine Adsorbed Grass Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Grass Pollen
NCT00118612Different Doses of Tyrosine Adsorbed Tree Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Tree Pollen
NCT04389034Influence of Specific Immunotherapy With Pollinex Quattro (Tree-/Grass Pollen) on Allergen-specific Immunoglobulin E (IgE) Levels
NCT02582073Dose Selection Study of Efficacy and Safety of Different Doses of Grass MATA MPL and Grass MATA Using mEECs™
NCT00387478Investigation of Efficacy and Safety of Tree MATAMPL,Tree MATA, and Placebo in Patients With Birch-Induced Seasonal Allergic Rhinitis
NCT03931993A Study of Tolerability and Safety of a New Cumulative Dose of Grass MATA MPL
NCT02557633A Study of Tolerability and Safety of Two New Doses of Grass MATA MPL
NCT00423787Efficacy and Safety/Tolerability of Ragweed MATA MPL
NCT00414141Efficacy and Safety/Tolerability of Grass MATA MPL
NCT00325338Follow-up Investigation of Efficacy of Ragweed MATAMPL,and Placebo in Patients With Ragweed-induced Seasonal Allergic Rhinitis
NCT00241410Safety, Immunological Effect and Efficacy of the Combined Application of MPL and Grass Pollen Allergen
NCT00118625Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Tree Pollen Allergy Vaccine
NCT00116285Assessment of Residual Allergenicity of Ragweed Pollen Allergoid With Monophosphoryl Lipid A (MPL) Using Skin Prick Testing
NCT00113750Induction of Immunogenicity With Different Doses of TreeMATA in Subjects Allergic to Tree Pollen
NCT00110786Investigation of Efficacy and Safety of Ragweed MATAMPL, Pollinex-R and Placebo in Patients With Ragweed Allergy
NCT00107705Assessment of Residual Allergenicity of Tree (Birch, Hazel, and Alder) Pollen Allergoid Using Skin Prick Testing
NCT00104377Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye Pollen
NCT00104390Assessment of Residual Allergenicity of Grass/Rye Pollen Allergoid Using Skin Prick Testing
NCT00417573Efficacy of IgIv in Patients With IgG Subclass Deficiency and Recurrent Infections
NCT00850668Peanut Allergy Vaccine Study in Healthy and Peanut-allergic Adults
NCT02210325Efficacy and Safety Study of Oral Solithromycin Compared to Intramuscular Ceftriaxone Plus Oral Azithromycin in the Treatment of Patients With Gonorrhea
NCT00089466Safety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV Infected Patients
NCT02411539Evaluating the Safety, Tolerability, and Effect of a Human Monoclonal Antibody (VRC01) on Markers of HIV Persistence in HIV-Infected Adults Receiving Antiretroviral Therapy (ART)
NCT00537394Optimizing Treatment for Treatment-Experienced, HIV-Infected People
NCT00376935Effectiveness of Palifermin in Increasing CD4 Counts in Treatment-Experienced HIV Infected Adults
NCT00270205Safety, Tolerability and Immune Response to LC002, an Experimental Therapeutic Vaccine, in Adults Receiving HAART
NCT00393276Determining Responses to Two Different Vaccines in HIV and HCV Infected Individuals
NCT00125983Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women
NCT00096850Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected Adults
NCT00082498Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected Patients
NCT00063804Safety of AMD070 When Administered Alone or Boosted With Low-Dose Ritonavir in HIV Uninfected Men
NCT00051831Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults
NCT00102986Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
NCT06031272Pausing Antiretroviral Treatment Under Structured Evaluation
NCT06205602Antiretrovirals Combined With Antibodies for HIV-1 Cure In Africa
NCT05985642Observational PIC Destination Cohort
NCT02859558Early ART to Limit Infection and Establishment of Reservoir
NCT06205589Therapeutic ID93 + GLA-SE Vaccination in Participants With Rifampicin-Susceptible Pulmonary TB
NCT04636437Doravirine for Persons With Excessive Weight Gain on Integrase Inhibitors and Tenofovir Alafenamide
NCT00031408Consent for Use of Stored Patient Specimens for Future Testing
NCT05156658Pharmacokinetic Interactions of ENG Subdermal Implants With Long-Acting Cabotegravir (CAB-LA) and LA Rilpivirine (RPV-LA) (CARLA)
NCT01936831High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB)